| Title |
Momordica charantia for type 2 diabetes mellitus
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2012
|
| DOI | 10.1002/14651858.cd007845.pub3 |
| Pubmed ID | |
| Authors |
Cheow Peng Ooi, Zaitun Yassin, Tengku-Aizan Hamid |
| Abstract |
Momordica charantia (bitter gourd) is not only a nutritious vegetable but it is also used in traditional medical practices to treat type 2 diabetes mellitus. Experimental studies with animals and humans suggested that the vegetable has a possible role in glycaemic control. |
Twitter Demographics
The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 17% |
| United States | 1 | 17% |
| Unknown | 4 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 363 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Ireland | 1 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 357 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 52 | 14% |
| Student > Master | 47 | 13% |
| Researcher | 46 | 13% |
| Student > Ph. D. Student | 38 | 10% |
| Student > Postgraduate | 15 | 4% |
| Other | 62 | 17% |
| Unknown | 103 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 115 | 32% |
| Nursing and Health Professions | 31 | 9% |
| Agricultural and Biological Sciences | 18 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Biochemistry, Genetics and Molecular Biology | 15 | 4% |
| Other | 50 | 14% |
| Unknown | 119 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2023.
All research outputs
#2,220,900
of 24,518,979 outputs
Outputs from Cochrane database of systematic reviews
#4,745
of 12,931 outputs
Outputs of similar age
#13,961
of 173,284 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 216 outputs
Altmetric has tracked 24,518,979 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,931 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,284 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.